Integral mean estimates for polynomials whose zeros are within a circle

Let p(z) be a polynomial of degree n having all its zeros in |z|≤k;  k≤1, then for each r>0, p>1, q>1 with p−1+q−1=1, Aziz and Ahemad (1996) recently proved that n{∫02π|p(eiθ)|rdθ}1/r≤{∫02π|1+keiθ|prdθ}1/pr{∫02π|p′(eiθ)|qrdθ}1/qr. In this paper, we extend the above inequality to the class of polynomials p(z)=anzn+∑v=μnan−vzn−v;1≤μ≤n having all its zeros in |z|≤k;  k≤1 and obtain a generalization as well as a refinement of the above result

Mountain-Shaped Coupler for Ultra Wideband Applications

This paper demonstrates a novel mountain-shaped design for a compact 3-dB coupler operating at ultra-wideband (UWB) frequencies from 3.1GHz to 10.6 GHz. The proposed design was accomplished using multilayer technology in which the structure is formed by three layers of conductors interleaved by a layer of substrate between each conductor layer. Simulation was carried out using CST Microwave Studio; the result was then compared with results from rectangular and star-shaped couplers that implemented the same technique. The results obtained show that the proposed new coupler has better performance compared to both rectangular and star-shaped coupler designs in terms of return loss, isolation, and phase difference. The coupler was fabricated and measured; the measurement results satisfactorily agree with the simulation results

A study on V-shaped microstrip patch MIMO antenna

A study on the V-shaped microstrip patch antenna for multiple-input multiple-output (MIMO) communication system based on the antenna orientation is performed. First the microstrip patch antenna operating at 2.45 GHz is calculated and simulated. Next, multiple elements of antennas for MIMO system is simulated and discussed. V-shaped with 45 degree slanted inward and outward is studied. The antenna properties are analyzed and compact antenna design is determined based on the simulation results. The dresults show the gap between antennas can be optimized to 1 mm while maintaining low mutual coupling. The gain of the MIMO antenna is 8.42 dBi. The simulated return losses, together with the radiation patterns, are presented and discussed

The Improvement of first Iteration Log Periodic Fractal Koch Antenna with Slot Implementation

In this paper, a slotted is introduced at each of the radiating elements on the 1st iteration log periodic fractal Koch antenna (LPFKA). The antenna is designed to testify the appropriate performance at UHF Digital television which operates from 4.0 GHz to 1.0 GHz. The dimension of the conventional 0th iteration LPKFA is successfully reduced by 17% with the implementation of slotted. The results show a good agreement with a stable radiation pattern across the operating bandwidth, stable gain more than 5 dBi and reflection coefficient of below -10 dB over the desired frequency range

Specially treated woven jute geotextiles for river bank protection

In this paper, studies on treatment of jute geotextile with isothiazolinone and fluorocarbon derivatives to impart antimicrobial and water repellent property have been reported for its improved end use specific performance. It is observed that the treated jute geotextile possesses higher durability in water as well as soil-water ambience

Dual Band to Wideband Pentagon-shaped Patch Antenna with Frequency Reconfigurability using EBGs

A dual band to wideband reconfigurable pentagon-shaped antenna with EBG unit cell is proposed. A minimal number of two EBG unit cell is deployed to realize frequency reconfigurable mechanism.  By varying the state of the EBG the antenna is capable to change its dual band operation to wideband alternately. There are three cases that have been analysed, first case is the EBG incorporated antenna with ideal and second is with the active EBG. Subsequently, the third cases is the fabricated ideal EBG incorporated antenna. The dual band operation is at 1.8 GHz and 5.2 GHz while the wide band from 1.6 GHz to 2.37 GHz (770 MHz). The proposed reconfigurable antenna is suitable to be implemented for LTE (1.6 GHz), Wi-Fi (5.2 GHz), WiMAX (2.3 GHz) and cognitive radio application

Tuberculosis treatment in the private healthcare sector in India: An analysis of recent trends and volumes using drug sales data

Background There is a pressing need for systematic approaches for monitoring how much TB treatment is ongoing in the private sector in India: both to cast light on the true scale of the problem, and to help monitor the progress of interventions currently being planned to address this problem. Methods We used commercially available data on the sales of rifampicin-containing drugs in the private sector, adjusted for data coverage and indication of use. We examined temporal, statewise trends in volumes (patient-months) of TB treatment from 2013 to 2016. We additionally analysed the proportion of drugs that were sold in combination packaging (designed to simplify TB treatment), or as loose pills. Results Drug sales suggest a steady trend of TB treatment dispensed by the private sector, from 18.4 million patient-months (95% CI 17.3–20.5) in 2013 to 16.8 patient-months (95% CI 15.5–19.0) in 2016. Overall, seven of 29 states in India accounted for more than 70% of national-level TB treatment volumes, including Uttar Pradesh, Maharashtra and Bihar. The overwhelming majority of TB treatment was dispensed not as loose pills, but in combination packaging with other TB drugs, accounting for over 96% of private sector TB treatment in 2017. Conclusions Our findings suggest consistent levels of TB treatment in the private sector over the past 4 years, while highlighting specific states that should be prioritized for intervention. Drug sales data can be helpful for monitoring a system as large, disorganised and opaque as India’s private sector

The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis

Introduction: The Antifibrinolytic Trialists Collaboration aims to increase knowledge about the effectiveness and safety of antifibrinolytic treatment by conducting individual patient data (IPD) meta-analyses of randomised trials. This article presents the statistical analysis plan for an IPD meta-analysis of the effects of antifibrinolytics for acute intracranial haemorrhage. Methods: The protocol for the IPD meta-analysis has been registered with PROSPERO (CRD42016052155). We will conduct an individual patient data meta-analysis of randomised controlled trials with 1000 patients or more assessing the effects of antifibrinolytics in acute intracranial haemorrhage. We will assess the effect on two co-primary outcomes: 1) death in hospital at end of trial follow-up, and 2) death in hospital or dependency at end of trial follow-up. The co-primary outcomes will be limited to patients treated within three hours of injury or stroke onset. We will report treatment effects using odds ratios and 95% confidence intervals. We use logistic regression models to examine how the effect of antifibrinolytics vary by time to treatment, severity of intracranial bleeding, and age. We will also examine the effect of antifibrinolytics on secondary outcomes including death, dependency, vascular occlusive events, seizures, and neurological outcomes. Secondary outcomes will be assessed in all patients irrespective of time of treatment. All analyses will be conducted on an intention-to-treat basis. Conclusions: This IPD meta-analysis will examine important clinical questions about the effects of antifibrinolytic treatment in patients with intracranial haemorrhage that cannot be answered using aggregate data. With IPD we can examine how effects vary by time to treatment, bleeding severity, and age, to gain better understanding of the balance of benefit and harms on which to base recommendations for practice

The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India

Background: India has 2.0 million estimated tuberculosis (TB) cases per annum with an estimated 280,000 TBrelated deaths per year. Understanding when in the course of TB treatment patients die is important for determining the type of intervention to be offered and crucially when this intervention should be given. The objectives of the current study were to determine in a large cohort of TB patients in India:- i) treatment outcomes including the number who died while on treatment, ii) the month of death and iii) characteristics associated with “early” death, occurring in the initial 8 weeks of treatment. Methods: This was a retrospective study in 16 selected Designated Microscopy Centres (DMCs) in Hyderabad, Krishna and Adilabad districts of Andhra Pradesh, South India. A review was performed of treatment cards and medical records of all TB patients (adults and children) registered and placed on standardized anti-tuberculosis treatment from January 2005 to September 2009. Results: There were 8,240 TB patients (5183 males) of whom 492 (6%) were known to have died during treatment. Case-fatality was higher in those previously treated (12%) and lower in those with extra-pulmonary TB (2%). There was an even distribution of deaths during anti-tuberculosis treatment, with 28% of all patients dying in the first 8 weeks of treatment. Increasing age and new as compared to recurrent TB disease were significantly associated with “early death”. Conclusion: In this large cohort of TB patients, deaths occurred with an even frequency throughout anti-TB treatment. Reasons may relate to i) the treatment of the disease itself, raising concerns about drug adherence, quality of anti-tuberculosis drugs or the presence of undetected drug resistance and ii) co-morbidities, such as HIV/ AIDS and diabetes mellitus, which are known to influence mortality. More research in this area from prospective and retrospective studies is needed